Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medprin Regenerative Medical Technologies Co Ltd
Cash from Investing Activities
Medprin Regenerative Medical Technologies Co Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
Cash from Investing Activities
-¥8.3m
|
CAGR 3-Years
70%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Investing Activities
-¥519.2m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Investing Activities
-¥6.7B
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-23%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Investing Activities
-¥705.3m
|
CAGR 3-Years
41%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Cash from Investing Activities
-¥892.5m
|
CAGR 3-Years
52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Investing Activities
-¥3.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
Medprin Regenerative Medical Technologies Co Ltd
Glance View
Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. The company is headquartered in Guangzhou, Guangdong and currently employs 271 full-time employees. The company went IPO on 2021-07-26. The firm's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The firm distributes its products both in the domestic market and to overseas markets.
See Also
What is Medprin Regenerative Medical Technologies Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-8.3m
CNY
Based on the financial report for Dec 31, 2024, Medprin Regenerative Medical Technologies Co Ltd's Cash from Investing Activities amounts to -8.3m CNY.
What is Medprin Regenerative Medical Technologies Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
38%
Over the last year, the Cash from Investing Activities growth was 90%. The average annual Cash from Investing Activities growth rates for Medprin Regenerative Medical Technologies Co Ltd have been 70% over the past three years , 38% over the past five years .
